Shares of Health Care sector company Seagen moved -0.2% today, and are now trading at a price of $212.72. The large-cap stock's daily volume was 1,298,100 compared to its average volume of 1,383,317. The S&P 500 index returned a 1.0% performance.
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company is based in Bothell and has 3,256 full time employees. Its market capitalization is $40,132,395,008.
11 analysts are following Seagen and have set target prices ranging from $228.0 to $229.0 per share. On average, they have given the company a rating of hold. At today's prices, SGEN is trading -7.07% away from its average analyst target price of $228.91 per share.
Over the last year, SGEN's share price has increased by 74.0%, which represents a difference of 60.0% when compared to the S&P 500. The stock's 52 week high is $217.51 per share whereas its 52 week low is $116.08. Seagen has averaged free cash flows of $-244787500.0 over the last 6 years, with a mean growth rate of -20.9%. It is unlikely that the stock can sustain its current performance trend for the long term when the underlying business is experiencing such poor cash flows.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | -540,151 | 161,060 | -701,211 | -32.03 |
| 2022 | -453,751 | 77,340 | -531,091 | 3.67 |
| 2021 | -499,007 | 52,330 | -551,337 | -171.22 |
| 2020 | 856,568 | 82,409 | 774,159 | 430.15 |
| 2019 | -163,737 | 70,753 | -234,490 | -4.33 |
| 2018 | -203,536 | 21,219 | -224,755 |
